Abstract

Patients infected by Leishmania braziliensis develop debilitating skin lesions. The role of inhibitory checkpoint receptors (ICRs) that induce T cell exhaustion during this disease is not known. Transcriptional profiling identified increased expression of ICRs including PD-1, PDL-1, PDL-2, TIM-3, and CTLA-4 in skin lesions of patients that was confirmed by immunohistology where there was increased expression of PD-1, TIM-3, and CTLA-4 in both CD4+ and CD8+ T cell subsets. Moreover, PDL-1/PDL-2 ligands were increased on skin macrophages compared to healthy controls. The proportions PD1+, but not TIM-3 or CTLA-4 expressing T cells in the circulation were positively correlated with those in the lesions of the same patients, suggesting that PD-1 may regulate T cell function equally in both compartments. Blocking PD-1 signaling in circulating T cells enhanced their proliferative capacity and IFN-γ production, but not TNF-α secretion in response to L. braziliensis recall antigen challenge in vitro. While we previously showed a significant correlation between the accumulation of senescent CD8+CD45RA+CD27- T cells in the circulation and skin lesion size in the patients, there was no such correlation between the extent of PD-1 expression by circulating on T cells and the magnitude of skin lesions suggesting that exhausted-like T cells may not contribute to the cutaneous immunopathology. Nevertheless, we identified exhausted-like T cells in both skin lesions and in the blood. Targeting this population by PD-1 blockade may improve T cell function and thus accelerate parasite clearance that would reduce the cutaneous pathology in cutaneous leishmaniasis.

Highlights

  • Leishmaniasis is caused by intracellular parasites belonging to Leishmania genus and has a global estimated prevalence of 12 million infected people, with 2 million new cases reported annually worldwide [1]

  • We found 9,955 genes identified as differentially expressed between the two groups that included inhibitory checkpoint receptors and their ligands that were uniquely associated with patient skin lesions (Figures 1B, C)

  • We investigated whether blockade of programmed death 1 (PD-1) signaling of circulating CD4+ and CD8+ T cells from cutaneous leishmaniasis (CL) patients, using antibodies to its ligands PDL-1 and PDL-2 blockade could enhance specific T cell functions linked to a leishmanicidal response after stimulation with L. braziliensis antigen (LbAg)

Read more

Summary

Introduction

Leishmaniasis is caused by intracellular parasites belonging to Leishmania genus and has a global estimated prevalence of 12 million infected people, with 2 million new cases reported annually worldwide [1]. Leishmania braziliensis is the most prevalent of the cutaneous species in Brazil, causing chronic infections and skin tissue damage associated with a wide spectrum of clinical manifestations [2, 3]. Increased production of TNF-a and non-specific cytotoxic mechanisms are linked to skin inflammation and lesion pathology [6, 7]. The absence of inhibitory mechanisms has been correlated with tissue damage and severity of CL [8]. Both insufficient and hyperactive non-specific immune responses may lead to pathology and provide avenues for therapeutic intervention

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call